PR98206

NEW DELHI, Oct. 10, 2022 /PRNewswire=KYODO JBN/

    Translumina - a global developer and manufacturer of innovative

cardiovascular medical devices, implants and access products - appointed

Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief

Operating Officer for the company's Europe operations.

    Indranil is a veteran in the healthcare industry. In his most recent role

as Managing Director at B. Braun Group in India, he turned around and delivered

sustainable profitable growth, managing several product lines (across three

production plants) and a team of over 2,000 colleagues in India.

    "Translumina presents a unique opportunity to build a leading Global

Med-tech company with a strong innovation culture and deep-seated roots in both

India and Germany. I look forward to driving the next chapter of growth for the

business that will involve bringing a further set of breakthrough technologies

to patients around the world, together with a passionate and committed team at

Translumina and supportive founders and shareholders," said Indranil.

    Armin has deep technical experience in the Med-tech industry encompassing

six sigma, lean manufacturing and change management best practices. He was

previously the Chief Operating Officer at Biedermann Motech, a developer and

manufacturer of innovative implants and instruments for spinal and extremity

surgery. Prior, Armin was site leader for Edward's manufacturing facility in

Switzerland.

    "Translumina presents a fascinating opportunity and intricate challenges.

The company's audacious culture, growth mindset and committed team is a great

fit with my values and aspirations and I look forward to building on our strong

R&D and manufacturing foundation in Germany," said Armin.

    "It's amazing to see how Translumina, which I co-founded with Punita Sharma

in 2010, has achieved a marquee position in the interventional cardiovascular

devices space in India and international markets. In addition to creating the

widely acclaimed Drug Eluting Stent technologies which represent the highest

standards of clinical evidence, we are now entering newer segments of specialty

balloons and structural heart with innovative transcatheter solutions for

Mitral, Aortic and Tricuspid valves. With Indranil and Armin complementing the

existing leadership of Paritosh Arora, India MD and Kewal Jindal, Group CFO, we

are all set to scale up and establish Translumina globally as an industry

standard in innovation, quality and clinical evidence in healthcare space

within next 2 years," said Gurmit Singh Chugh, Chairman and Co-founder

Translumina

    Arjun Oberoi, Managing Director, Everstone Capital, said, "Translumina is

very well positioned to enter its next phase of growth and the new leadership

will bring a lot of value in assimilating a broader product portfolio and

building robust go-to-market strategies in key geographies".

    About Translumina

    Incorporated in 2010, Translumina is an interventional cardiovascular

device company that delivers world-class products and services. It is a fully

integrated product development and manufacturing company with manufacturing

facilities in Germany and India. Over the years, we have created strategic

partnerships with leading hospitals, engineering institutes, global

technological companies and renowned interventional cardiologists. Translumina

combines the best of German engineering, intellectual property and high-quality

standards with India's entrepreneurial culture and strong capabilities in

manufacturing innovative products at affordable prices.

    For more information, visit www.translumina.com

    About Everstone Capital

    Singapore-headquartered Everstone Capital, the private equity arm of the

Everstone Group (everstonegroup.com[http://www.everstonegroup.com/]), is a

global firm committed to driving economic growth and creating sustainable

value. With seven offices globally (Singapore, Mumbai, Delhi, Bengaluru, New

York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with

control mindset and growth bias; comprising best of breed investing, operations

and strategic resources with significant experience and skills.

    For more information, visit everstonecapital.com

[https://everstonecapital.com/] and

https://www.linkedin.com/company/everstonecapital/

    Logo: https://mma.prnewswire.com/media/1797972/Translumina_Logo.jpg

Source: Translumina